LYEL
Price
$0.61
Change
-$0.04 (-6.15%)
Updated
Dec 18, 04:59 PM (EDT)
70 days until earnings call
PTCHF
Price
$2.20
Change
+$0.05 (+2.33%)
Updated
Dec 16 closing price
Ad is loading...

LYEL vs PTCHF

Header iconLYEL vs PTCHF Comparison
Open Charts LYEL vs PTCHFBanner chart's image
Lyell Immunopharma
Price$0.61
Change-$0.04 (-6.15%)
Volume$30.1K
CapitalizationN/A
PureTech Health
Price$2.20
Change+$0.05 (+2.33%)
Volume$3.2K
CapitalizationN/A
LYEL vs PTCHF Comparison Chart
Loading...
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTCHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LYEL vs. PTCHF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYEL is a Hold and PTCHF is a Buy.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (LYEL: $0.65 vs. PTCHF: $2.20)
Brand notoriety: LYEL and PTCHF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYEL: 91% vs. PTCHF: 26%
Market capitalization -- LYEL: $195.87M vs. PTCHF: $516.56M
LYEL [@Biotechnology] is valued at $195.87M. PTCHF’s [@Biotechnology] market capitalization is $516.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYEL’s FA Score shows that 0 FA rating(s) are green whilePTCHF’s FA Score has 1 green FA rating(s).

  • LYEL’s FA Score: 0 green, 5 red.
  • PTCHF’s FA Score: 1 green, 4 red.
According to our system of comparison, PTCHF is a better buy in the long-term than LYEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYEL’s TA Score shows that 4 TA indicator(s) are bullish while PTCHF’s TA Score has 4 bullish TA indicator(s).

  • LYEL’s TA Score: 4 bullish, 5 bearish.
  • PTCHF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, PTCHF is a better buy in the short-term than LYEL.

Price Growth

LYEL (@Biotechnology) experienced а -29.43% price change this week, while PTCHF (@Biotechnology) price change was +2.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

LYEL is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTCHF($487M) has a higher market cap than LYEL($189M). PTCHF YTD gains are higher at: -7.563 vs. LYEL (-66.706). PTCHF has higher annual earnings (EBITDA): -53.65M vs. LYEL (-197.45M). PTCHF has more cash in the bank: 502M vs. LYEL (441M). PTCHF has less debt than LYEL: PTCHF (24M) vs LYEL (51.4M). LYEL has higher revenues than PTCHF: LYEL (63K) vs PTCHF (0).
LYELPTCHFLYEL / PTCHF
Capitalization189M487M39%
EBITDA-197.45M-53.65M368%
Gain YTD-66.706-7.563882%
P/E RatioN/AN/A-
Revenue63K0-
Total Cash441M502M88%
Total Debt51.4M24M214%
FUNDAMENTALS RATINGS
PTCHF: Fundamental Ratings
PTCHF
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LYELPTCHF
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
68%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 17 days ago
83%
Bullish Trend 17 days ago
67%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 7 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
66%
View a ticker or compare two or three
Ad is loading...
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTCHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MEFAX13.54N/A
N/A
MassMutual Mid Cap Growth A
WFALX21.05-0.06
-0.28%
Allspring Index Asset Allocation C
HEOSX16.44-0.13
-0.78%
Hartford Climate Opportunities R4
CMIRX8.34-0.11
-1.30%
Conestoga Discovery Institutional
RICIX9.66-0.20
-2.00%
T. Rowe Price Intl Disciplined Eq I

LYEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYEL has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LYEL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYEL
1D Price
Change %
LYEL100%
-3.65%
VCYT - LYEL
46%
Loosely correlated
-2.52%
RCKT - LYEL
45%
Loosely correlated
+1.36%
NTLA - LYEL
44%
Loosely correlated
-1.87%
PRME - LYEL
42%
Loosely correlated
-3.00%
ALLO - LYEL
41%
Loosely correlated
+0.49%
More

PTCHF and

Correlation & Price change

A.I.dvisor tells us that PTCHF and KURA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTCHF and KURA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTCHF
1D Price
Change %
PTCHF100%
N/A
KURA - PTCHF
30%
Poorly correlated
-2.36%
PRTC - PTCHF
30%
Poorly correlated
-1.58%
STTK - PTCHF
24%
Poorly correlated
+5.50%
LYEL - PTCHF
23%
Poorly correlated
-3.65%
BCTX - PTCHF
22%
Poorly correlated
+6.17%
More